RAD18 and colorectal cancer: miR-145 antagonizes SNAI1-mediated stemness and radiation resistance in colorectal cancer [107], and reversed 5-fluorouracil (5-FU) drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer [108].